Please login to the form below

Not currently logged in
Email:
Password:

Verily Life Sciences

This page shows the latest Verily Life Sciences news and features for those working in and with pharma, biotech and healthcare.

Bayer looks to leverage AI across the pharma value chain

Bayer looks to leverage AI across the pharma value chain

The company is, he said, “all over this”, having already collaborated with the likes of Verily, the life sciences unit at Google parent company Alphabet, and IBM’s Watson and Deep

Latest news

  • Google’s Verily backs $300m European life sciences fund Google’s Verily backs $300m European life sciences fund

    Google’s life sciences unit Verily has joined the backers of a new $300m investment fund that seeks to support late-stage drug development companies in Europe. ... Andrew Conrad, CEO of Verily, said: “We are excited to partner with Medicxi, Novartis

  • Verily's Baseline health project seeks 10,000 volunteers Verily's Baseline health project seeks 10,000 volunteers

    Four-year study to produce a molecular snapshot. Alphabet's life sciences unit Verily has kicked off a project that will examine the risk factors that come into play as a ... The initiative comes under the Verily (formerly Google Life Sciences) Project

  • Sanofi sets up diabetes joint venture with Google's Verily Sanofi sets up diabetes joint venture with Google's Verily

    Sanofi is already one of the biggest players in insulin and other diabetes medicines, but will now set up a joint venture with Verily Life Sciences - called Onduo - that will bring ... Verily has already made waves in the life sciences sector with

  • GSK and Google launch bioelectronics venture GSK and Google launch bioelectronics venture

    Will develop electronic implants to treat chronic diseases, including diabetes. GlaxoSmithKline has joined forces with Google's Verily Life Sciences to establish a new company dedicated to the development of bioelectronic ... The UK pharma firm will own

  • Sanofi's diabetes head Pascale Witz to leave the company Sanofi's diabetes head Pascale Witz to leave the company

    She was instrumental in signing important strategic collaborations, including those with Verily Life Sciences (a subsidiary of Google) and Hanmi Pharmaceuticals.”.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Going beyond the pill: Verily Life Sciences creates a new diabetes joint venture with Sanofi. ... 600. Verily / Sanofi. JV. Co-investment to form Onduo combining Sanofi's diabetes expertise with Verily's software, data analytics and devices.

  • Deal Watch August 2016 Deal Watch August 2016

    It has now made a major leap forward with the setting up of a $0.7bn joint venture with Verily Life Sciences, formerly Google Life Sciences. ... 1, 575. Verily (US), formerly Google Life Sciences. GlaxoSmithKline (UK). Joint venture.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Who will be the new disrupter of HCP media

    Apple’s health Apps are now implicitly part of their products, and Alphabet’s life sciences arm, Verily Life Sciences, is doing some incredible things in partnership with the pharmaceutical industry. ... Such as the GSK/Verily joint venture called

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics